1 |
Forni D, Cagliani R, Clerici M, Sironi M. 2018. Origin and dispersal of Hepatitis E virus. Emerg. Microbes Infect. 7: 11.
|
2 |
Tam AW, Smith MM, Guerra ME, Huang CC, Bradley DW, Fry KE, et al. 1991. Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome. Virology 185: 120-131.
DOI
|
3 |
Kang S, Myoung J. 2017. Host innate immunity against Hepatitis E virus and viral evasion mechanisms. J. Microbiol. Biotechnol. 27: 1727-1735.
DOI
|
4 |
Kumar S, Subhadra S, Singh B, Panda BK. 2013. Hepatitis E virus: the current scenario. Int. J. Infect. Dis. 17: e228-233.
DOI
|
5 |
Krawczynski K. 1993. Hepatitis E. Hepatology 17: 932-941.
DOI
|
6 |
Wong DC, Purcell RH, Sreenivasan MA, Prasad SR, Pavri KM. 1980. Epidemic and endemic hepatitis in India: evidence for a non-A, non-B hepatitis virus aetiology. Lancet 2: 876-879.
|
7 |
Khuroo MS. 1980. Study of an epidemic of non-A, non-B hepatitis. Possibility of another human hepatitis virus distinct from post-transfusion non-A, non-B type. Am. J. Med. 68: 818-824.
DOI
|
8 |
Reyes GR, Purdy MA, Kim JP, Luk KC, Young LM, Fry KE, et al. 1 990. Isolation o f a cDNA f rom the virus responsible for enterically transmitted non-A, non-B hepatitis. Science 247: 1335-1339.
DOI
|
9 |
Jilani N, Das BC, Husain SA, Baweja UK, Chattopadhya D, Gupta RK, et al. 2007. Hepatitis E virus i nf ection and fulminant hepatic failure during pregnancy. J. Gastroenterol. Hepatol. 22: 676-682.
DOI
|
10 |
Navaneethan U, Al Mohajer M, Shata MT. 2008. Hepatitis E and pregnancy: understanding the pathogenesis. Liver Int. 28: 1190-1199.
DOI
|
11 |
Kang HS, Myoung J, So EY, Bahk YY, Kim BS. 2016. Transgenic expression of non-structural genes of Theiler's virus suppresses initial viral replication and pathogenesis of demyelination. J. Neuroinflammation 13: 133.
DOI
|
12 |
Zitvogel L, Galluzzi L, Kepp O, Smyth MJ, Kroemer G. 2015. Type I interferons in anticancer immunity. Nat. Rev. Immunol. 15: 405-414.
DOI
|
13 |
Kim N, Now H, Nguyen NTH, Yoo JY. 2016. Multilayered regulations of RIG-I in the anti-viral signaling pathway. J. Microbiol. 54: 583-587.
DOI
|
14 |
Schmidt ME, Varga SM. 2017. Modulation of the host immune response by respiratory syncytial virus proteins. J. Microbiol. 55: 161-171.
DOI
|
15 |
Gillen J, Li W, Liang Q, Avey D, Wu J, Wu F, et al. 2015. A survey of the interactome of Kaposi's sarcoma-associated herpesvirus ORF45 revealed its binding to viral ORF33 and cellular USP7, resulting in stabilization of ORF33 that is required for production of progeny viruses. J. Virol. 89: 4918-4931.
DOI
|
16 |
Ha S, Choi IS, Choi C, Myoung J. 2016. Infection models of human norovirus: challenges and recent progress. Arch. Virol. 161: 779-788.
DOI
|
17 |
Lee M, Seo DJ, Seo J, Oh H, Jeon SB, Ha SD, et al. 2015. Detection of viable murine norovirus using the plaque assay and propidium-monoazide-combined real-time reverse transcription-polymerase chain reaction. J. Virol. Methods 221: 57-61.
DOI
|
18 |
Karpe YA, Lole KS. 2011. Deubiquitination activity associated with hepatitis E virus putative papain-like cysteine protease. J. Gen. Virol. 92: 2088-2092.
DOI
|
19 |
Oshiumi H, Miyashita M, Matsumoto M, Seya T. 2013. A distinct role of Riplet-mediated K63-Linked polyubiquitination of the RIG-I repressor domain in human antiviral innate immune responses. PLoS Pathog. 9: e1003533.
DOI
|
20 |
Akira S, Uematsu S, Takeuchi O. 2006. Pathogen recognition and innate immunity. Cell 124: 783-801.
DOI
|
21 |
Kang S, Myoung J. 2017. Primary lymphocyte infection models for KSHV and its putative tumorigenesis mechanisms in B cell lymphomas. J. Microbiol. 55: 319-329.
DOI
|
22 |
Medzhitov R. 2007. Recognition of microorganisms and activation of the immune response. Nature 449: 819-826.
DOI
|
23 |
Kang S, Choi C, Choi I, Han KN, Roh SW, Choi J, et al. 2018. Hepatitis E virus methyltransferase inhibits type I interferon induction by targeting RIG-I. J. Microbiol. Biotechnol. doi: 10.4014/jmb.1808.08058 [Epub ahead of print]
|
24 |
Draenert R, Frater J, Prado JG. 2012. Virus immune evasion: new mechanism and implications in disease outcome. Adv. Virol. 2012: 490549.
|
25 |
Senba M, Mori N. 2012. Mechanisms of virus immune evasion lead to development from chronic inflammation to cancer formation associated with human papillomavirus infection. Oncol Rev. 6(2): e17.
DOI
|
26 |
Uddin MB, Lee BH, Nikapitiya C, Kim JH, Kim TH, Lee HC, et al. 2016. Inhibitory effects of bee venom and its components against viruses in vitro and in vivo. J. Microbiol. 54: 853-866.
DOI
|
27 |
Nan Y, Yu Y, Ma Z, Khattar SK, Fredericksen B, Zhang YJ. 2014. Hepatitis E virus inhibits type I interferon induction by ORF1 products. J. Virol. 88: 11924-11932.
DOI
|
28 |
Theofilopoulos AN, Baccala R, Beutler B, Kono DH. 2005. Type I interferons (alpha/beta) in immunity and autoimmunity. Annu. Rev. Immunol. 23: 307-336.
DOI
|
29 |
Surjit M, Varshney B, Lal SK. 2012. The ORF2 glycoprotein of hepatitis E virus inhibits cellular NF-kappaB activity by blocking ubiquitination mediated proteasomal degradation of IkappaBalpha in human hepatoma cells. BMC Biochem. 13: 7.
DOI
|
30 |
Lee BH, Chathuranga K, Uddin MB, Weeratunga P, Kim MS, Cho WK, et al. 2017. Coptidis Rhizoma extract inhibits replication of respiratory syncytial virus in vitro and in vivo by inducing antiviral state. J. Microbiol. 55: 488-498.
DOI
|
31 |
Seong RK, Choi YK, Shin OS. 2016. MDA7/IL-24 is an antiviral factor that inhibits influenza virus replication. J. Microbiol. 54: 695-700.
DOI
|
32 |
Lai HC, Horng YT, Yeh PF, Wang JY, Shu CC, Lu CC, et al. 2016. The assessment of host and bacterial proteins in sputum from active pulmonary tuberculosis. J. Microbiol. 54: 761-767.
DOI
|
33 |
Weeratunga P, Uddin MB, Kim MS, Lee BH, Kim TH, Yoon JE, et al. 2016. Interferon-mediated antiviral activities of Angelica tenuissima Nakai and its active components. J. Microbiol. 54: 57-70.
DOI
|
34 |
Weeratunga P, Herath TUB, Kim TH, Lee HC, Kim JH, Lee BH, et al. 2017. Dense Granule Protein-7 (GRA-7) of Toxoplasma gondii inhibits viral replication in vitro and in vivo. J. Microbiol. 55: 909-917.
DOI
|
35 |
Loo YM, Fornek J, Crochet N, Bajwa G, Perwitasari O, Martinez-Sobrido L, et al. 2008. Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J. Virol. 82: 335-345.
DOI
|
36 |
Takeuchi O, Akira S. 2010. Pattern recognition receptors and inflammation. Cell 140: 805-820.
DOI
|
37 |
Kawai T, Takahashi K, Sato S, Coban C, Kumar H, Kato H, et al. 2005. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat. Immunol. 6: 981-988.
DOI
|
38 |
Hamid FB, Kim J, Shin CG. 2017. Characterization of prototype foamy virus infectivity in transportin 3 knockdown human 293t cell line. J. Microbiol. Biotechnol. 27: 380-387.
DOI
|
39 |
He M, Wang M, Huang Y, Peng W, Zheng Z, Xia N, et al. 2016. The ORF3 protein of genotype 1 Hepatitis E virus suppresses TLR3-induced NF-kappaB signaling via TRADD and RIP1. Sci. Rep. 6: 27597.
DOI
|
40 |
Choi S, Park H, Minelko M, Kim EK, Cho MR, Nam JH. 2017. Recombinant adeno-associated virus expressing truncated IK cytokine diminishes the symptoms of inflammatory arthritis. J. Microbiol. Biotechnol. 27: 1892-1895.
DOI
|
41 |
Lee JM, Cho JB, Ahn HC, Jung W, Jeong YJ. 2017. A novel chemical compound for inhibition of SARS coronavirus helicase. J. Microbiol. Biotechnol. 27: 2070-2073.
DOI
|
42 |
Liu X, Dong Y, Wang J, Li L, Zhong Z, Li YP, et al. 2017. VSV-G viral envelope glycoprotein prepared from Pichia pastoris enhances transfection of DNA into animal cells. J Microbiol Biotechnol. 27: 1098-1105.
|
43 |
Ahn HS, Han SH, Kim YH, Park BJ, Kim DH, Lee JB, et al. 2017. Adverse fetal outcomes in pregnant rabbits experimentally infected with rabbit hepatitis E virus. Virology 512: 187-193.
DOI
|
44 |
Cho M, Myoung J. 2015. OX40 and 4-1BB downregulate Kaposi's sarcoma-associated herpesvirus replication in lymphatic endothelial cells, but 4-1BB and not OX40 inhibits viral replication in B-cells. J. Gen. Virol. 96: 3635-3645.
DOI
|
45 |
Fu B, Kuang E, Li W, Avey D, Li X, Turpin Z, et al. 2015. Activation of p90 ribosomal S6 kinases by ORF45 of Kaposi's sarcoma-associated herpesvirus is critical for optimal production of infectious viruses. J. Virol. 89: 195-207.
DOI
|
46 |
Liu S, Cai X, Wu J, Cong Q, Chen X, Li T, et al. 2015. Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation. Science 347: aaa2630.
DOI
|
47 |
Meylan E, Curran J, Hofmann K, Moradpour D, Binder M, Bartenschlager R, et al. 2005. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437: 1167-1172.
DOI
|
48 |
Seth RB, Sun L, Ea CK, Chen ZJ. 2005. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 122: 669-682.
DOI
|
49 |
Grandvaux N, Servant MJ, tenOever B, Sen GC, Balachandran S, Barber GN, et al. 2002. Transcriptional profiling of interferon regulatory factor 3 target genes: direct involvement in the regulation of interferon-stimulated genes. J. Virol. 76: 5532-5539.
DOI
|
50 |
Honda K, Takaoka A, Taniguchi T. 2006. Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors. Immunity 25: 349-360.
DOI
|